You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High intermediate risk prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Prostate Cancer Trial in Rome (Decapeptyl)

Recruiting
  • Prostate Cancer
  • Rome, Lazio, Italy
  • +2 more
Sep 23, 2022

Prostate Cancer Trial in Cairo (Prostate Only Radiation, Prostate and Pelvic Lymph Node Radiation)

Recruiting
  • Prostate Cancer
  • Prostate Only Radiation
  • Prostate and Pelvic Lymph Node Radiation
  • Cairo, Egypt
    National Cancer Institute - Cairo University
Aug 9, 2022

Prostate Cancer, Cancer of the Prostate Trial in Saint Louis (device, radiation, drug)

Recruiting
  • Prostate Cancer
  • Cancer of the Prostate
  • Ethos Varian treatment system
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 19, 2023

Prostate Cancer Trial in Rotterdam (Adaptive radiotherapy according to UPRATE protocol)

Recruiting
  • Prostate Cancer
  • Adaptive radiotherapy according to UPRATE protocol
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Centre
Jul 26, 2022

Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • Cancer Of Prostate
  • M9241
  • Stereotactic Body Radiation Therapy (SBRT)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Prostate Cancer Trial in Baltimore (Enoblituzumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 16, 2022

Prostate Cancer, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Trial in San

Recruiting
  • Prostate Cancer
  • Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
  • TRANBERG®|Thermal Therapy System
  • San Diego, California
    Genesis Research LLC.
Apr 12, 2023

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Prostate Cancer Trial in Pittsburgh (18F-DCFPyL)

Active, not recruiting
  • Prostate Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 8, 2022

Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)

Recruiting
  • Prostate Cancer
  • Low dose rate prostate brachytherapy
  • High Dose Rate prostate brachytherapy
  • Kelowna, British Columbia, Canada
    British Columbia Cancer Agency Center for the Southern Interior
Mar 3, 2022

Prostate Cancer, Prostatic Adenocarcinoma Trial in New York (degarelix injection, androgen deprivation therapy)

Active, not recruiting
  • Prostate Cancer
  • Prostatic Adenocarcinoma
  • degarelix injection
  • androgen deprivation therapy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 28, 2022

ABlative Radiotherapy (for) Unfavorable Prostate Tumors

Recruiting
  • Prostate Cancer
    • Monza, MB, Italy
      Radiation Oncology, ASST Monza (University of Milan Bicocca)
    Jul 21, 2022

    Prostate Cancer Trial (Dasatinib)

    Withdrawn
    • Prostate Cancer
    • (no location specified)
    Feb 23, 2022

    Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

    Recruiting
    • Prostate Adenocarcinoma
    • +7 more
    • High-Dose Rate Brachytherapy
    • Stereotactic Body Radiation Therapy
    • Los Angeles, California
      University of California at Los Angeles / Jonsson Comprehensive
    Oct 13, 2022

    Prostate Cancer Trial in Switzerland (Radical prostatectomy (RP) followed by ePLND, Radical prostatectomy (RP) only)

    Active, not recruiting
    • Prostate Cancer
    • Radical prostatectomy (RP) followed by ePLND
    • Radical prostatectomy (RP) only
    • Aarau, Switzerland
    • +10 more
    Feb 24, 2022

    Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

    Completed
    Has Results
    • Stage II Prostate Adenocarcinoma
    • Stage III Prostate Adenocarcinoma
    • Palo Alto, California
      Stanford University, School of Medicine
    Mar 2, 2022

    Prostate Cancer Trial in United States (Androgen deprivation therapy (ADT), Brachytherapy, Hypofractionated pelvic External beam

    Recruiting
    • Prostate Cancer
    • Androgen deprivation therapy (ADT)
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Nov 2, 2022

    Prostate Cancer Trial in Stanford (F18-DCFPyL, Gadolinium, Positron emission tomography (PET)/Magnetic Resonance Imaging (MRI)

    Temporarily not available
    • Prostate Cancer
    • Stanford, California
      Stanford University
    Apr 4, 2022

    Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)

    Approved for marketing
    • Prostatic Neoplasms
    • +4 more
    • 68GA PSMA-HBED-CC
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Mar 11, 2022

    Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Chicago, Illinois
      University of Chicago
    Sep 30, 2021

    Prostate Adenocarcinoma Trial in Salt Lake City (MVA-BN-Brachyury)

    Withdrawn
    • Prostate Adenocarcinoma
    • MVA-BN-Brachyury
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Sep 21, 2021

    Prostate Cancer Trial in Bronx (IGRT 45 Gy in 5 fractions of 9 Gy, IGRT 24 Gy single dose, Dexamethasone)

    Recruiting
    • Prostate Cancer
    • IGRT 45 Gy in 5 fractions of 9 Gy
    • +3 more
    • Bronx, New York
      Montefiore Medical Center - Moses Campus
    Aug 19, 2021

    Prostate Adenocarcinoma Trial in Park Ridge (CyberKnife, Androgen Deprivation Therapy (ADT), Intensity Modulated radiation

    Recruiting
    • Prostate Adenocarcinoma
    • CyberKnife
    • +2 more
    • Park Ridge, Illinois
      Advocate Lutheran General Hospital
    Jul 19, 2021